RT Journal Article
SR Electronic
T1 Does Physician Over-Service Improve the Quality of Care? A Standardised Patient Audit Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.30.23297802
DO 10.1101/2023.10.30.23297802
A1 Si, Yafei
A1 Bateman, Hazel
A1 Chen, Shu
A1 Hanewald, Katja
A1 Li, Bingqin
A1 Su, Min
A1 Zhou, Zhongliang
YR 2023
UL http://medrxiv.org/content/early/2023/10/31/2023.10.30.23297802.abstract
AB Physicians’ “know-do gaps” are a key factor driving the poor quality of healthcare in many developing countries, but there is little guidance on how to address these gaps. We designed a standardised patient audit study in China to evaluate the impact of physician over-service on their investment in learning and disease management decisions. We find that physicians’ total over-service leads to a 19.2%, 15.6% and 10.8% significant increase in consultation length, adherence to checklists, and patient-centred communication, respectively, but no significant improvement in giving a correct diagnosis, drug prescription or referral. The effects on physicians’ investment in learning are driven by over-service in drug prescription rather than over-service in medical tests. Moreover, over-service in drug prescription significantly leads to a 28.0 percentage-point increase in the prescription of a correct drug. Our findings imply that physician over-service reduces their “know-do gaps” and improves healthcare quality despite the related inefficient use of medical resources.JEL classification D82; H75; I10; I11; I18; J45Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the China Medical Board, USA (15-227); National Natural Science Foundation of China, China (71874137); the University of New South Wales, Australia; Australian Research Council Centre of Excellence in Population Ageing Research (project CE170100005), Australia.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee of Xi'an Jiaotong University Health Science Centre (Approval number: 2015-406) and the Ethics Committee of the University of New South Wales (HC210354).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes